Related Experiment Video
Updated: May 12, 2026
Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
Published on: February 1, 2017
Hepatitis B Virus Infection: A Mini Review
Diana Asema Asandem1,2, Selorm Philip Segbefia3, Kwadwo Asamoah Kusi3
1West African Center for Cell Biology of Infectious Pathogens, University of Ghana, Accra P.O. Box LG 52, Ghana.
Insights
Hepatitis B virus (HBV) infection remains a global health challenge due to limited understanding of its genomic features and pathogenesis. Further research is crucial for developing better treatments and prevention strategies for chronic HBV.
Area of Science:
- Hepatology
- Virology
- Genomics
Background:
- Hepatitis B virus (HBV) and Hepatitis C virus (HCV) are primary causes of end-stage liver disease globally.
- Despite an HBV vaccine, new infections persist, particularly in regions with inadequate vaccination policies.
- Chronic HBV infection lacks a cure, necessitating a deeper understanding of viral biology for effective management.
Purpose of the Study:
- To explore the genomic basis of HBV activities and their role in infection establishment and progression.
- To enhance understanding of the virus-host interplay in determining HBV infection outcomes.
- To investigate the impact of HBV and HCV coinfections on disease progression and treatment response.
Main Methods:
- Review of current research on HBV genomic features and pathogenesis.
- Analysis of the complex interplay between HBV and the host immune system.
- Examination of data from hyperendemic regions regarding disease progression and treatment.
Main Results:
- Significant gaps remain in understanding HBV genomic features and their impact on pathogenesis.
- The complex virus-host interactions are critical in determining infection outcomes.
- Inadequate knowledge exists on disease progression and treatment response, especially in hyperendemic areas.
Conclusions:
- In-depth studies on HBV biology and genomics are essential for improved management and prevention.
- Understanding viral genetics may pave the way for a potential cure for chronic HBV infection.
- Further research is needed to address the impact of coinfections and regional disparities.
Abstract:
Hepatitis B and C viruses (HBV and HCV) are the leading causes of end-stage liver disease worldwide. Although there is a potent vaccine against HBV, many new infections are recorded annually, especially in poorly resourced places which have lax vaccination policies. Again, as HBV has no cure and chronic infection is lifelong, vaccines cannot help those already infected. Studies to thoroughly understand the HBV biology and pathogenesis are limited, leaving much yet to be understood about the genomic features and their role in establishing and maintaining infection. The current knowledge of the impact on disease progression and response to treatment, especially in hyperendemic regions, is inadequate. This calls for in-depth studies on viral biology, mainly for the purposes of coming up with better management strategies for infected people and more effective preventative measures for others. This information could also point us in the direction of a cure. Here, we discuss the progress made in understanding the genomic basis of viral activities leading to the complex interplay of the virus and the host, which determines the outcome of HBV infection as well as the impact of coinfections.
More Related Videos
Related Concept Videos
01:27Cytomegalovirus Disease
01:25Hepatitis
01:19Encephalitis l: Introduction
01:28Viral Hepatitis I: Introduction
01:23Cirrhosis I: Introduction
01:24Cirrhosis II: Pathophysiology